The CDC's plan to consolidate disease data, including information on measles and polio, with Palantir raises issues surrounding patient privacy and delays in tracking long-term health trends. This development follows the Biden administration's push to modernize aging data systems, propelled by the Covid-19 pandemic. However, increased use of Palantir by the Trump administration has sparked distrust among state officials about sharing data. Critics worry that merging sensitive health information might endanger individuals' privacy, especially those needing gender or reproductive health care.
The C.D.C.'s shift to consolidate disease data with Palantir raises significant concerns about patient privacy and potential delays in identifying long-term health trends.
Officials express anxiety over Palantir's expansion in federal data management, fearing that the new system might compromise sensitive health information.
Collection
[
|
...
]